The effect of alpha-adrenergic blockade on the cardiopulmonary response to ketamine.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000777:Anesthetics / Q000037:antagonists & inhibitors*; D000778:Anesthetics, Dissociative / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D003510:Cyclohexanes / Q000037:antagonists & inhibitors*; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006863:Hydrogen-Ion Concentration; D007649:Ketamine; D008297:Male; D010100:Oxygen / Q000097:blood; D010276:Parasympatholytics / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011941:Receptors, Adrenergic; D012119:Respiration / Q000187:drug effects*; D013147:Spirometry; D013268:Stimulation, Chemical; D014630:Vagus Nerve / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000037:antagonists & inhibitors*
D000317:Adrenergic alpha-Antagonists; D000777:Anesthetics; D000778:Anesthetics, Dissociative; D003510:Cyclohexanes; D010276:Parasympatholytics; D011941:Receptors, Adrenergic; D014662:Vasoconstrictor Agents; D002245:Carbon Dioxide; D007649:Ketamine; D001285:Atropine; D010100:Oxygen; D010646:Phentolamine